Adam Rocker

Gelsana Therapeutics, Inc.

NIH Rank #40026
  • Early Career

NIH Funding · FY2024

Total Funding
$325K
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#40,026
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $325K across 1 grant · National rank #40026.

Top grants by award amount

Adam Rocker's NIH grant portfolio, ranked by award amount.

  • 1R43DK141293-01R43
    Advancing Diabetic Foot Ulcer Treatment with Provasliex, a Controlled PDGF Release Hydrogel for Promoting Vascularization and Managing Overactive Inflammation
    $325K
    award amount

Affiliation

Institutions that have administered grants for Adam Rocker.

Affiliated with Gelsana Therapeutics, Inc. (CO).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Gelsana Therapeutics, Inc.